so on quick read of the Lancet article, the cells had excellent implantation. There were no complications and the patients had slight visual improvement and definitely no worsening of vision. This is excellent news given how severe the vision loss was in these patients. This is only the begining but this is a great start. Hopefully the news media will pick up on this. Go ACTC
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.